YTHDF1 and posterior cortical atrophy: Control, EZH2-, and YTHDF1-deficient PCa cells were treated with either cycloheximide (CHX) to block the de novo protein synthesis, or MG-132 to inhibit proteasomal degradation, followed by immunoblot analyses.